Literature DB >> 4622308

Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.

R L Wendt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4622308

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  14 in total

1.  Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Authors:  Christopher Louizos; Jaime A Yáñez; M Laird Forrest; Neal M Davies
Journal:  J Pharm Pharm Sci       Date:  2014       Impact factor: 2.327

2.  Intra-individual comparison of the action of equal doses of isosorbide-5-endomononitrate, slow-release isosorbide dinitrate and placebo in patients with coronary heart disease.

Authors:  G Müller; W Häcker; B Schneider
Journal:  Klin Wochenschr       Date:  1983-04-15

3.  Isosorbide dinitrate and isoxsuprine in exercise induced asthma.

Authors:  W M Tullett; K R Patel
Journal:  Br Med J (Clin Res Ed)       Date:  1983-06-18

4.  Kinetics of isosorbide dinitrate and relationships to pharmacological effects.

Authors:  H L Fung; E F McNiff; D Ruggirello; A Darke; U Thadani; J O Parker
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

5.  Concentrations of the vasodilator isosorbide dinitrate and its metabolites in the blood of human subjects.

Authors:  L F Chasseaud; W H Down; R K Grundy
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

6.  First data on effects and pharmacokinetics of isosorbide-5-mononitrate in normal man.

Authors:  U Abshagen; S Spörl-Radun
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

7.  Vascular effects of the dinitrate and moninitrate esters of isosorbide, isomannide and isoidide.

Authors:  M G Bogaert; M T Rosseel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

8.  Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions.

Authors:  W Schneider; G Menke; R Heidemann; P Satter; M Kaltenbach; N Rietbrock
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

9.  Pharmacokinetics of stereomeric 1,4:3,6-dianhydrohexitol mononitrates in rats.

Authors:  T B Tzeng; H L Fung
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

10.  Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.

Authors:  S J Shane; J J Iazzetta; A W Chisholm; J F Berka; D Leung
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.